| An SI Board Since April 1998 |
| Posts |
SubjectMarks |
Bans |
Symbol |
| 1640 |
16 |
0
|
KAHI |
|
KAIRE HOLDING INCORPORATED: $0.50 stock-$3 to $4 Book Value
Consolidated combined KAHI revenues are estimated at $50-$55 million
First two months of 1998, consolidated revenues have already exceeded $5 million
(OTC: BB; KAHI) Based in Los Angeles, Kaire Holdings Inc. is a diversified group of companies that collectively provide a range of products and services.
On December 9, 1997, KAHI acquired Kaire International, a Colorado based network marketing company. Kaire has been in operation for over six years and is best known for its successful introduction of Pycnogenol. Revenues for the year end December 31, 1997 where in excess of $35 million.
In addition to the U.S. Growth in revenues, KAHI's potential growth profitability is also related to the success of its strategy for penetration in the international market place with strategic partners, the first of which is Mainland China which was announced on January 20, 1998. Included in the exclusive mutual sales agreement with Potamac Chemicals - Singapore are existing direct sales licenses for Thailand, the Philippines, Taiwan and Malaysia. As A result of the acquisition Kaire will also gain access to Indonesia through an affiliated company, which in 1997 did $27 million in multi-level marketing sales.
Based on Potamacs current Shareholder's Equity account of $12.5 million this affiliation should add $1.00 per share to Kaire's Book Value. In addition to potential benefits from Potamac Chemicals affiliation, Kaire Holdings could further add another $2 to $3 dollars per share to its current book value in the event that its subsidiary Kaire International's S-1 registration statement, filed on February 11, 1998 , becomes effective.
|
|
|
